The latest on Brain Health and Resilience, plus a few fun Brain Teasers

By SharpBrains | November 30, 2020

Wel­come to a new edi­tion of Sharp­Brains’ e‑newsletter, fea­tur­ing fas­ci­nat­ing neu­ro­science find­ings and tips, com­bined with fun brain teasers. #1. To cel­e­brate this quite-chal­leng­ing Thanks­giv­ing, here are five fun brain teasers that read­ers have enjoyed the most this year so far. It is always good to learn more about (and appre­ci­ate) that most pre­cious resource…

Read More

Click Therapeutics and Boehringer Ingelheim partner to develop and market a digital therapeutic to treat schizophrenia

By SharpBrains | September 21, 2020

Boehringer Ingel­heim, Click Ther­a­peu­tics ink $500M+ dig­i­tal ther­a­peu­tics devel­op­ment, com­mer­cial­iza­tion deal (Mobi­Health­News): Inter­na­tion­al phar­ma Boehringer Ingel­heim and pre­scrip­tion dig­i­tal ther­a­peu­tics com­pa­ny Click Ther­a­peu­tics have inked a $500 mil­lion-plus deal to joint­ly devel­op and com­mer­cial­ize a dig­i­tal treat­ment for patients with schizophrenia.

Read More

Digital mental health taking off in Europe

By SharpBrains | January 31, 2020

___ These 10 Euro­pean tech star­tups want to help you improve your men­tal fit­ness (Sil­i­con Canals): “Accord­ing to a report by WHO Euro (World Health Organ­i­sa­tion Europe), in many west­ern coun­tries, men­tal health dis­or­ders are the major cause of dis­abil­i­ty, account­ing for 30% to 40% of chron­ic sick leaves, and cost­ing near­ly 3% of GDP.…

Read More

Study finds psychiatric diagnoses to be ‘scientifically meaningless’

By SharpBrains | August 15, 2019

__________ Psy­chi­atric diag­no­sis ‘sci­en­tif­i­cal­ly mean­ing­less’ (Sci­ence Dai­ly): “A new study, pub­lished in Psy­chi­a­try Research, has con­clud­ed that psy­chi­atric diag­noses are sci­en­tif­i­cal­ly worth­less as tools to iden­ti­fy dis­crete men­tal health dis­or­ders. The study, led by researchers from the Uni­ver­si­ty of Liv­er­pool, involved a detailed analy­sis of five key chap­ters of the lat­est edi­tion of the wide­ly used…

Read More

Epigenetics research opens potential door to prevent neurodevelopmental disorders

By SharpBrains | August 20, 2018

___ Epi­ge­net­ic Changes Guide Devel­op­ment of Dif­fer­ent Brain Regions (Dana Foun­da­tion): “It’s one of the great­est stand­ing mys­ter­ies in neu­ro­science: Giv­en that each cell in the human body con­tains the same DNA, how, exact­ly, does the brain devel­op into dis­tinct func­tion­al regions, sup­port­ed by dif­fer­ent cell types? And how might that devel­op­men­tal pro­gram go awry,…

Read More

Study: Psychedelics can promote neural plasticity in the prefrontal cortex and expand pathways for mental health

By SharpBrains | August 17, 2018

Psy­che­delics in Neu­rol­o­gy: Poten­tial for Improv­ing Neu­ro­plas­tic­i­ty (Neu­rol­o­gy­Times): “Back in the 1950s, research was prov­ing that psy­che­del­ic agents could be effec­tive in the treat­ment of var­i­ous neu­ropsy­chi­atric dis­or­ders. Unfor­tu­nate­ly, just as sci­ence was explor­ing their ben­e­fi­cial effects, the coun­ter­cul­ture was explor­ing and embrac­ing their effects. Slow­ly but sure­ly, psy­che­delics were asso­ci­at­ed with rebel­lious youth and…

Read More